At least in the case of drug markets it is not necessarily a matter of too much or little regulation but rather a matter of bad vs good regulations: https://sl

At least in the case of drug markets it is not necessarily a matter of too much or little regulation but rather a matter of bad vs good regulations: https://slatestarcodex.com/2016/08/29/reverse-voxsplaining-drugs-vs-chairs/ https://slatestarcodex.com/2016/08/29/reverse-voxsplaining-d... In the famous case of epipens it is true that a complete absence of price control is a problem, but the price spike was also made possible by the de facto epipens manifacturing monopoly granted by the FDA. In this case there are heavy regulation regarding entering a market AND few regulations inside the market. EDIT: changed insulin to epipens to match the article